Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

152 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A multicenter prospective phase II randomized trial of epirubicin/vinorelbine versus pegylated liposomal doxorubicin/vinorelbine as first-line treatment in advanced breast cancer. A GOIM study.
Vici P, Colucci G, Giotta F, Sergi D, Filippelli G, Perri P, Botti C, Vizza E, Carpino A, Pizzuti L, Latorre A, Giannarelli D, Lopez M, Di Lauro L. Vici P, et al. Among authors: pizzuti l. J Exp Clin Cancer Res. 2011 Apr 12;30(1):39. doi: 10.1186/1756-9966-30-39. J Exp Clin Cancer Res. 2011. PMID: 21481280 Free PMC article. Clinical Trial.
[Specificity of action of anticancer agents].
Vici P, Sergi D, Pizzuti L, Vincenzoni C, Vizza E, Tomao F, Morace N, Toglia G, Mancini E, Baiocco E, Di Lauro L, Botti C, Sindico S, Lopez M. Vici P, et al. Among authors: pizzuti l. Clin Ter. 2011;162(2):137-49. Clin Ter. 2011. PMID: 21533321 Italian.
A multicenter phase II randomized trial of docetaxel/gemcitabine versus docetaxel/capecitabine as first-line treatment for advanced breast cancer: a Gruppo Oncologico Italia Meridionale study.
Vici P, Giotta F, Di Lauro L, Sergi D, Vizza E, Mariani L, Latorre A, Pizzuti L, D'Amico C, Giannarelli D, Colucci G. Vici P, et al. Among authors: pizzuti l. Oncology. 2011;81(3-4):230-6. doi: 10.1159/000334432. Epub 2011 Nov 17. Oncology. 2011. PMID: 22094540 Clinical Trial.
Effectiveness of neoadjuvant trastuzumab and chemotherapy in HER2-overexpressing breast cancer.
Natoli C, Vici P, Sperduti I, Grassadonia A, Bisagni G, Tinari N, Michelotti A, Zampa G, Gori S, Moscetti L, De Tursi M, Panebianco M, Mauri M, Ferrarini I, Pizzuti L, Ficorella C, Samaritani R, Mentuccia L, Iacobelli S, Gamucci T. Natoli C, et al. Among authors: pizzuti l. J Cancer Res Clin Oncol. 2013 Jul;139(7):1229-40. doi: 10.1007/s00432-013-1436-y. Epub 2013 Apr 20. J Cancer Res Clin Oncol. 2013. PMID: 23604446 Free PMC article.
Vitamin D supplementation and breast cancer prevention: a systematic review and meta-analysis of randomized clinical trials.
Sperati F, Vici P, Maugeri-Saccà M, Stranges S, Santesso N, Mariani L, Giordano A, Sergi D, Pizzuti L, Di Lauro L, Montella M, Crispo A, Mottolese M, Barba M. Sperati F, et al. Among authors: pizzuti l. PLoS One. 2013 Jul 22;8(7):e69269. doi: 10.1371/journal.pone.0069269. Print 2013. PLoS One. 2013. PMID: 23894438 Free PMC article. Review.
Gemcitabine-oxaliplatin (GEMOX) as salvage treatment in pretreated epithelial ovarian cancer patients.
Vici P, Sergi D, Pizzuti L, Mariani L, Arena MG, Barba M, Maugeri-Saccà M, Vincenzoni C, Vizza E, Corrado G, Paoletti G, Tomao F, Tomao S, Giannarelli D, Di Lauro L. Vici P, et al. Among authors: pizzuti l. J Exp Clin Cancer Res. 2013 Aug 8;32(1):49. doi: 10.1186/1756-9966-32-49. J Exp Clin Cancer Res. 2013. PMID: 23927758 Free PMC article. Clinical Trial.
152 results